A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial
Authors
Keywords
-
Journal
HEALTH TECHNOLOGY ASSESSMENT
Volume -, Issue -, Pages 1-108
Publisher
National Institute for Health and Care Research
Online
2023-11-06
DOI
10.3310/vpdt7105
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US
- (2021) Donovan T. Maust et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trends in antipsychotic prescribing among long‐term care residents receiving hospice care
- (2021) Lauren B. Gerlach et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- (2021) Sube Banerjee et al. LANCET
- Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates
- (2020) Monika Marcinkowska et al. CNS DRUGS
- Healthcare utilization and monetary costs associated with agitation in UK care home residents with advanced dementia: a prospective cohort study
- (2020) A. Buylova Gola et al. INTERNATIONAL PSYCHOGERIATRICS
- Time to invest in prevention and better care of behaviors and psychological symptoms associated with dementia
- (2020) Claire V. Burley et al. INTERNATIONAL PSYCHOGERIATRICS
- Becoming or Remaining Agitated: The Course of Agitation in People with Dementia Living in Care Homes. The English Longitudinal Managing Agitation and Raising Quality of Life (MARQUE) Study
- (2020) Louise Marston et al. JOURNAL OF ALZHEIMERS DISEASE
- Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) study
- (2019) Monica Panca et al. PLoS One
- Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators
- (2019) Joan Forns et al. JOURNAL OF AFFECTIVE DISORDERS
- Comparative Efficacy of Interventions for Aggressive and Agitated Behaviors in Dementia
- (2019) Jennifer A. Watt et al. ANNALS OF INTERNAL MEDICINE
- Temporal Trends in the Use of Anticholinergic Drugs Among Older People Living in Long-Term Care Facilities in Helsinki
- (2019) Ulla L. Aalto et al. DRUGS & AGING
- Antidepressant use and risk of adverse outcomes in people aged 20–64 years: cohort study using a primary care database
- (2018) Carol Coupland et al. BMC Medicine
- Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis
- (2018) Khachen Kongpakwattana et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Association of the Centers for Medicare & Medicaid Services’ National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014
- (2018) Donovan T. Maust et al. JAMA Internal Medicine
- The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer's Disease in Three European Countries – Study Design and Baseline Findings
- (2018) Anders Wimo et al. JOURNAL OF ALZHEIMERS DISEASE
- Improving the quality of life of care home residents with dementia: Cost-effectiveness of an optimized intervention for residents with clinically significant agitation in dementia
- (2018) Renee Romeo et al. Alzheimers & Dementia
- Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease
- (2018) Reetta Kettunen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Dementia prevention, intervention, and care
- (2017) Gill Livingston et al. LANCET
- Cost-effectiveness of yoga for managing musculoskeletal conditions in the workplace
- (2017) N Hartfiel et al. OCCUPATIONAL MEDICINE-OXFORD
- Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial
- (2016) Lon S. Schneider et al. AMERICAN JOURNAL OF PSYCHIATRY
- Longitudinal course of behavioural and psychological symptoms of dementia: systematic review
- (2016) Rianne M. van der Linde et al. BRITISH JOURNAL OF PSYCHIATRY
- Use of Benzodiazepines in Alzheimer’s Disease: A Systematic Review of Literature
- (2015) Michaela Defrancesco et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A pilot randomized controlled trial of a self-management group intervention for people with early-stage dementia (The SMART study)
- (2015) Catherine Quinn et al. INTERNATIONAL PSYCHOGERIATRICS
- Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia
- (2015) Jeffrey L. Cummings et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Monetary costs of agitation in older adults with Alzheimer's disease in the UK: prospective cohort study
- (2015) S. Morris et al. BMJ Open
- Assessment and management of behavioral and psychological symptoms of dementia
- (2015) H. C. Kales et al. BMJ-British Medical Journal
- Assessment and management of behavioral and psychological symptoms of dementia
- (2015) H. C. Kales et al. BMJ-British Medical Journal
- Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
- (2014) S Banerjee et al. HEALTH TECHNOLOGY ASSESSMENT
- START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia
- (2014) Gill Livingston et al. HEALTH TECHNOLOGY ASSESSMENT
- Effect of Citalopram on Agitation in Alzheimer Disease
- (2014) Anton P. Porsteinsson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial
- (2012) Renee Romeo et al. BRITISH JOURNAL OF PSYCHIATRY
- METHODS FOR COVARIATE ADJUSTMENT IN COST-EFFECTIVENESS ANALYSIS THAT USE CLUSTER RANDOMISED TRIALS
- (2012) Manuel Gomes et al. HEALTH ECONOMICS
- Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial
- (2012) Chris Fox et al. PLoS One
- Estimating Preference-Based Single Index Measures for Dementia Using DEMQOL and DEMQOL-Proxy
- (2012) Donna Rowen et al. VALUE IN HEALTH
- Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets
- (2012) Ben van Hout et al. VALUE IN HEALTH
- Predictors of costs of care in Alzheimer’s disease: A multinational sample of 1222 patients
- (2011) Anders Gustavsson et al. Alzheimers & Dementia
- Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
- (2011) Pierre N. Tariot ARCHIVES OF GENERAL PSYCHIATRY
- Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial
- (2011) Sube Banerjee et al. LANCET
- The efficacy of mirtazapine in agitated patients with Alzheimer’s disease: A 12-week open-label pilot study
- (2011) Sibel Cakir Neuropsychiatric Disease and Treatment
- Course of Neuropsychiatric Symptoms in Residents with Dementia in Nursing Homes Over 2-Year Period
- (2010) Roland B. Wetzels et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Treatment and prevention of depression after surgery for hip fracture in older people: Cost-effectiveness analysis
- (2010) Renee Romeo et al. JOURNAL OF AFFECTIVE DISORDERS
- Prevalence of Neuropsychiatric Symptoms and Their Association with Functional Limitations in Older Adults in the United States: The Aging, Demographics, and Memory Study
- (2010) Toru Okura et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population
- (2009) George M. Savva et al. BRITISH JOURNAL OF PSYCHIATRY
- Effect of Oxcarbazepine in the Treatment of Agitation and Aggression in Severe Dementia
- (2009) Oskar H. Sommer et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Management of agitation and aggression associated with Alzheimer disease
- (2009) Clive G. Ballard et al. Nature Reviews Neurology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started